• Home
  • R&D
Redefining Healthy Longevity
Through Precision Immune Resilience

Platform

Business Strategy

Three Engines for Sustainable Growth

Revenue Today. Data for Tomorrow. Therapies for the Future.

IMMUNIQUE’s growth strategy is powered by three core engines.

PRIME-NK

Revenue & Clinical Evidence Engine

Generating Early Revenue and
Accumulating RWD Through
Regenerative Medicine Services

  • Regenerative Medicine
  • Early Revenue Generation
  • RWD Accumulation
  • Post-Treatment Recovery Validation

Revenue → Real-World Data
→ Clinical Insight

IMMUNOKINE

Knowledge & IP Creation Engine

Building a Strong Pipeline
Through Continuous Data
and IP Accumulation

  • Peptide Libraries
  • Mechanism Discovery
  • Mechanistic Data
  • Patent Portfolio Expansion
  • Multi-Indication Potential

Data → Knowledge
→ IP Expansion

AUTO-Treg

Long-Term Growth Engine

A Long-Term Growth Engine
with the Potential to Lead the
Autoimmune Disease Market

  • Next-Generation Treg Therapies
  • Autoimmune Disease Leadership
  • Strategic Growth Optionality
  • Global Partnering & Licensing
  • Transformational Value Potential

Strategic Optionality → Validation
→ Scalable Growth

Data & Insight Flow

RWD and clinical insights drive a cycle of platform advancement and therapeutic innovation